Member Center | Contact Us | Site Map | Archives | Photos | Alerts | Mobile Edition | Subscribe to the paper
 
Biogen Idec Inc  BIIB
 Performance   more  
Growth of $10,00005-23-13
Total Return%201020112012YTD
 Stock25.364.133.058.9
 +/- Industry21.554.32.630.2
 +/- S&P 50012.564.119.643.2
 
 Key Stats   
Last Close (05-23-13)$232.62
Market Cap $Mil35,270
Sales $Mil5,425
Morningstar Style Box Large Growth
Industry Biotechnology
Sector Healthcare
Stock Type  Aggressive Growth
Morningstar Stock Grades
Growth B
Profitability B
Financial Health A
 Valuation   more  12-24-12 
StockIndustryS&P 500
Price/Earnings25.944.115.8
Forward P/E20.7---14.2
Price/Book5.36.12.0
Price/Cash Flow19.525.17.8
Price/Sales6.66.01.2
Dividend Yield %------2.1
S&P 500 data through 12-24-12
 Growth   more  12-31-11 
1 Year%
3 Year%
S&P 500
Sales7.07.29.0
Net Income22.816.413.6
EPS27.923.914.0
Equity/Share18.39.611.1
Dividends------5.2
S&P 500 data - 3 Year%
 Profitability   more  09-30-12 
StockIndustryS&P 500
ROA %15.17.38.5
ROE %21.514.920.5
  Net Margin %25.614.413.4
  Asset Turnover0.60.50.8
  Fin Leverage2.57.5
Sales/Employee
$Thousands		1085.0------
Stock uses trailing 12 months. Industry and S&P 500 use fiscal year-end.
 Earnings Trends   more  09-30-12 
Historical years use fiscal year-end.
 Fund Ownership  more  
 % Shares Held % Fund Assets Star Rating
Vanguard PRIMECAP Inv 5.01 6.04 4 stars
Fidelity Contrafund 3.61 1.51 4 stars
American Funds Growth Fund of Amer A 2.55 0.79 3 stars
Legg Mason ClearBridge Aggressive Gr A 1.66 9.88 3 stars
American Funds AMCAP A 1.41 2.10 3 stars
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2013 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.